Mark as
Advancing Progress in the Development of Combination Cancer Therapies with Immune Checkpoint Inhibitors
More by National Academies of Sciences, Engineering, and Medicine
Recent activity
Rate this book to see your activity here.
Comments and reviews
Please sign in to leave a comment